There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend title XI of the Social Security Act to require drug manufacturers to publicly justify unnecessary price increases.


Actions Overview (1)

Date
02/13/2019Introduced in Senate

All Actions (1)

Date
02/13/2019Read twice and referred to the Committee on Finance.
Action By: Senate

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Finance02/13/2019 Referred to

As of 05/21/2019 no related bill information has been received for S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019.


Subjects (8)


Latest Summary (1)

There is one summary for S.474. View summaries

Shown Here:
Introduced in Senate (02/13/2019)

Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019

This bill requires manufacturers of drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill.

A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.